EMEA-000409-PIP01-08-M06
Key facts
Invented name |
Tivicay
|
Active substance |
Dolutegravir (DTG)
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0267/2021
|
PIP number |
EMEA-000409-PIP01-08-M06
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
ViiV Healthcare UK Ltd.
United Kingdom |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000409-PIP01-08-M06
|
Compliance opinion date |
15/10/2021
|
Compliance outcome |
positive
|